van Dijk, Louisa J. D. http://orcid.org/0000-0002-6507-5666
,
Harki, Jihan
van Noord, Desirée
Verhagen, Hence J. M.
Kolkman, Jeroen J.
Geelkerken, Robert H.
Bruno, Marco J.
Moelker, Adriaan
Funding for this research was provided by:
Atrium Maquet Getinge Group (Unrestricted grant)
Article History
Received: 21 October 2018
Accepted: 23 July 2019
First Online: 20 August 2019
Ethics approval and consent to participate
: The CoBaGI trial is performed in accordance with the Declaration of Helsinki and the Dutch law regarding research involving human subjects (Wet Medisch wetenschappelijk Onderzoek met mensen (WMO)). The Institutional Review Board of Erasmus MC University Medical Center, Rotterdam, the Netherlands approved the study protocol with identification number MEC-2013-476 on 15 October 2013. The boards of the other five Dutch participating centers gave permission for conducting the trial in their center: Maasstad Hospital in Rotterdam on 12 November 2015, Medisch Spectrum Twente in Enschede on 9 June 2016, St. Antonius Hospital in Nieuwegein on 14 September 2016, Bernhoven Hospital in Uden on 28 November 2016 and Jeroen Bosch Hospital in ‘s-Hertogenbosch on 23 November 2017. Informed consent will be obtained from all study participants.
: Not applicable.
: LvD: no competing interests. JH: no competing interests. DvN: no competing interests. HV: no competing interests. JK: no competing interests. RG: no competing interests. MB: no competing interests. AM: no competing interests.